Recent trends in the prevalence of chronic kidney disease: Not the same old song

Current Opinion in Nephrology and Hypertension

Volumn 26, Issue 3, 2017, Pages 187-196

  Hsua, Raymond K ^a   Powe, Neil R ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Chronic kidney disease; Epidemiology; Prevalence; Temporal trends

Indexed keywords

AGRICULTURAL WORKER; BLACK PERSON; CHINA; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENGLAND; ENVIRONMENTAL EXPOSURE; ESTIMATED GLOMERULAR FILTRATION RATE; HUMAN; HYPERTENSION; KOREA; MEXICAN AMERICAN; MICROALBUMINURIA; NORWAY; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; TEMPORAL ANALYSIS; TREND STUDY; UNITED STATES; CENTRAL AMERICA; ETHNOLOGY; GLOMERULUS FILTRATION RATE; RISK FACTOR; SOUTH KOREA;

CENTRAL AMERICA; CHINA; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; ENGLAND; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; NORWAY; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; REPUBLIC OF KOREA; RISK FACTORS; UNITED STATES;

EID: 85015706320     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0000000000000315     Document Type: Review

References (48)

1. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
2. Hsu RK, Hsu CY. Proteinuria and reduced glomerular filtration rate as risk factors for acute kidney injury. Curr Opin Nephrol Hypertens 2011; 20:211-217.
3. Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
4. National Center for Health Statistics. National Health and Nutrition Examination Survey. Atlanta, GA: Centers for Disease Control and Prevention; 2016; Edited by.
5. Hsu CY, Vittinghoff E, Lin F, Shlipak MG. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 2004; 141:95-101.
6. Coresh J, Selvin E, Stevens L, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298:2038-2047.
7. Grams ME, Juraschek SP, Selvin E, et al. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine-and cystatin C-based estimates. Am J Kidney Dis 2013; 62:253-260.
8. Radhakrishnan J, Remuzzi G, Saran R, et al. Taming the chronic kidney disease epidemic: a global view of surveillance efforts. Kidney Int 2014; 86:246-250.
9. Hoerger TJ, Simpson SA, Yarnoff BO, et al. The future burden of CKD in the United States: a simulation model for the CDC CKD initiative. Am J Kidney Dis 2015; 65:403-411.
10. Murphy D, McCulloch CE, Lin F, et al. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med 2016; 165:473-481.
11. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
12. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005; 16:180-188.
13. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11:155Aabst.
14. Levey AS, Coresh J, Greene T, et al., Collaboration CKDE. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145:247-254.
15. Foley RN, Wang C, Snyder JJ, Collins AJ. Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANES. Clin J Am Soc Nephrol 2009; 4:965-972.
16. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis 2008; 51:395-406.
17. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367:20-29.
18. Afkarian M, Zelnick LR, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA 2016; 316:602-610.
19. Hsu RK, Hsu CY. Temporal trends in prevalence of CKD: the glass is half full and not half empty. Am J Kidney Dis 2013; 62:214-216.
20. Aitken GR, Roderick PJ, Fraser S, et al. Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010. BMJ Open 2014; 4:e005480.
21. Hallan SI, Ovrehus MA, Romundstad S, et al. Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway. Kidney Int 2016; 90:665-673.
22. Lee SW, Kim YC, Oh SW, et al. Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES). Nephrol Dial Transplant 2011; 26:3975-3980.
23. Selvin E, Manzi J, Stevens LA, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis 2007; 50:918-926.
24. Plantinga LC, Miller ER, Stevens LA, et al., Team CfDCaPCKDS. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006. Hypertension 2009; 54:47-56.
25. Yoon SS, Gu Q, Nwankwo T, et al. Trends in blood pressure among adults with hypertension: United States, 2003 to 2012. Hypertension 2015; 65:54-61.
26. Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med 2014; 160:517-525.
27. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. Circulation 2012; 126:2105-2114.
28. Gu Q, Paulose-Ram R, Dillon C, Burt V. Antihypertensive medication use among US adults with hypertension. Circulation 2006; 113:213-221.
29. de Boer IH, Afkarian M, Rue TC, et al., Group DCaCTEoDIaCDER. Renal outcomes in patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 2014; 25:2342-2350.
30. De Nicola L, Minutolo R. Worldwide growing epidemic of CKD: fact or fiction? Kidney Int 2016; 90:482-484.
31. Kang HT, Lee J, Linton JA, et al. Trends in the prevalence of chronic kidney disease in Korean adults: the Korean National Health and Nutrition Examination Survey from 1998 to 2009. Nephrol Dial Transplant 2013; 28:927-936.
32. Stanifer JW, Muiru A, Jafar TH, Patel UD. Chronic kidney disease in low-and middle-income countries. Nephrol Dial Transplant 2016; 31:868-874.
33. Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012; 379:815-822.
34. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17:2937-2944.
35. Kovesdy CP, Kalantar-Zadeh K. Enter the dragon: a Chinese epidemic of chronic kidney disease? Lancet 2012; 379:783-785.
36. Zhang L, Long J, Jiang W, et al. Trends in chronic kidney disease in China. N Engl J Med 2016; 375:905-906.
37. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362:1090-1101.
38. Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013; 310:948-959.
39. Correa-Rotter R, Wesseling C, Johnson RJ. CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy. Am J Kidney Dis 2014; 63:506-520.
40. Wesseling C, Crowe J, Hogstedt C, et al. Resolving the enigma of the mesoamerican nephropathy: a research workshop summary. Am J Kidney Dis 2014; 63:396-404.
41. Torres C, Aragó n A, Gonzá lez M, et al. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis 2010; 55:485-496.
42. O'Donnell JK, Tobey M, Weiner DE, et al. Prevalence of and risk factors for chronic kidney disease in rural Nicaragua. Nephrol Dial Transplant 2011; 26:2798-2805.
43. Peraza S, Wesseling C, Aragon A, et al. Decreased kidney function among agricultural workers in El Salvador. Am J Kidney Dis 2012; 59:531-540.
44. Orantes CM, Herrera R, Almaguer M, et al. Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009. MEDICC Rev 2011; 13:14-22.
45. Jayasumana C, Orantes C, Herrera R, et al. Chronic interstitial nephritis in agricultural communities: a worldwide epidemic with social, occupational and environmental determinants. Nephrol Dial Transplant 2016. [Epub ahead of print]
46. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311:507-520.
47. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
48. Wright JT, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373:2103-2116.